Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
64.8M
-
Shares change
-
+1.53M
-
Total reported value, excl. options
-
$853M
-
Value change
-
+$21.5M
-
Put/Call ratio
-
8.52
-
Number of buys
-
70
-
Number of sells
-
-56
-
Price
-
$13.17
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q4 2024
180 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q4 2024.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.8M shares
.
Largest 10 shareholders include Deep Track Capital, LP (5.97M shares), BlackRock, Inc. (5.18M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.63M shares), FMR LLC (3.88M shares), VANGUARD GROUP INC (3.23M shares), Paradigm Biocapital Advisors LP (3.2M shares), Redmile Group, LLC (2.9M shares), Blue Owl Capital Holdings LP (2.77M shares), DEUTSCHE BANK AG\ (2.55M shares), and TRV GP IV, LLC (2.13M shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.